CC
Commodore Capital Portfolio holdings
AUM
$1.42B
This Quarter Return
+49.77%
1 Year Return
+73.3%
3 Year Return
+1,330.82%
5 Year Return
–
10 Year Return
–
AUM
$664M
AUM Growth
+$664M
(+6.7%)
Cap. Flow
+$28.1M
Cap. Flow
% of AUM
4.24%
Top 10 Holdings %
Top 10 Hldgs %
60.97%
Holding
41
New
11
Increased
8
Reduced
7
Closed
6
Top Buys
| 1 |
Nuvalent
NUVL
|
$27.2M |
| 2 |
Immunovant
IMVT
|
$20.4M |
| 3 |
Arcellx
ACLX
|
$18.3M |
| 4 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$14M |
| 5 |
4D Molecular Therapeutics
FDMT
|
$13.3M |
Top Sells
| 1 |
Cytokinetics
CYTK
|
$43.3M |
| 2 |
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
|
$22.3M |
| 3 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$20.7M |
| 4 |
Viridian Therapeutics
VRDN
|
$19.8M |
| 5 |
Akero Therapeutics
AKRO
|
$11.3M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cabaletta Bio
CABA
$137M
| $9.35M | 1.41% |
+1,010,359
| New | +$9.35M |
|
27
Vaxcyte
PCVX
$4.08B
| $8.32M | 1.25% |
+173,481
| New | +$8.32M |
|
28
Karyopharm Therapeutics
KPTI
$59M
| $6.58M | 0.99% |
1,935,609
| – | – |
|
|
THRD
29
DELISTED
Third Harmonic Bio
THRD
| $4.27M | 0.64% |
993,294
-25,275
| -2% | -$109K |
|
30
Larimar Therapeutics
LRMR
$326M
| $3.1M | 0.47% |
750,000
| – | – |
|
31
Acumen Pharmaceuticals
ABOS
$83.6M
| $2.69M | 0.41% |
498,315
-601,685
| -55% | -$3.25M |
|
32
Immunic
IMUX
$76.8M
| $2.52M | 0.38% |
1,800,000
+906,987
| +102% | +$1.27M |
|
33
Rezolute
RZLT
$622M
| $2.51M | 0.38% |
1,210,000
| – | – |
|
34
KalVista Pharmaceuticals
KALV
$733M
| $2.11M | 0.32% |
312,553
| – | – |
|
|
DBVT
35
DBV Technologies
DBVT
$250M
| $142K | 0.02% |
+92,687
| New | +$142K |
|
|
36
Cytokinetics
CYTK
$5.79B
| – | – |
-893,646
| Closed | -$43.3M |
|
37
Esperion Therapeutics
ESPR
$472M
| – | – |
-467,468
| Closed | -$3.13M |
|
38
Terns Pharmaceuticals
TERN
$638M
| – | – |
-205,870
| Closed | -$1.21M |
|
|
STSA
39
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| – | – |
-3,711,286
| Closed | -$22.3M |
|
|
TCDA
40
DELISTED
Tricida, Inc. Common Stock
TCDA
| – | – |
-1,975,403
| Closed | -$20.7M |
|
|
BLSA
41
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| – | – |
-250,000
| Closed | -$2.51M |
|